BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 24045621)

  • 1. Hypoxia and tumor metabolism in radiation oncology: targets visualized by positron emission tomography.
    Wijsman R; Kaanders JH; Oyen WJ; Bussink J
    Q J Nucl Med Mol Imaging; 2013 Sep; 57(3):244-56. PubMed ID: 24045621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of hypoxia PET imaging in radiation therapy planning.
    Geets X; Grégoire V; Lee JA
    Q J Nucl Med Mol Imaging; 2013 Sep; 57(3):271-82. PubMed ID: 24045623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of hypoxia in radiation oncology: pathophysiology, tumor biology and implications for treatment.
    Busk M; Horsman MR
    Q J Nucl Med Mol Imaging; 2013 Sep; 57(3):219-34. PubMed ID: 24045619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodological aspects on hypoxia PET acquisition and image processing.
    Thorwarth D; Mönnich D; Zips D
    Q J Nucl Med Mol Imaging; 2013 Sep; 57(3):235-43. PubMed ID: 24045620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revisit 18F-fluorodeoxyglucose oncology positron emission tomography: "systems molecular imaging" of glucose metabolism.
    Shen B; Huang T; Sun Y; Jin Z; Li XF
    Oncotarget; 2017 Jun; 8(26):43536-43542. PubMed ID: 28402949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of Tumor Metabolism Using Positron Emission Tomography (PET).
    Apostolova I; Wedel F; Brenner W
    Recent Results Cancer Res; 2016; 207():177-205. PubMed ID: 27557539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current preclinical and clinical applications of hypoxia PET imaging using 2-nitroimidazoles.
    Peeters SG; Zegers CM; Yaromina A; Van Elmpt W; Dubois L; Lambin P
    Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):39-57. PubMed ID: 25517080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular imaging of hypoxia.
    Oyen WJ; Kaanders JH; Bussink J
    Q J Nucl Med Mol Imaging; 2013 Sep; 57(3):217-8. PubMed ID: 24045618
    [No Abstract]   [Full Text] [Related]  

  • 9. F-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapy.
    Rajendran JG; Krohn KA
    Semin Nucl Med; 2015 Mar; 45(2):151-62. PubMed ID: 25704387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia PET/CT imaging: implications for radiation oncology.
    Arabi M; Piert M
    Q J Nucl Med Mol Imaging; 2010 Oct; 54(5):500-9. PubMed ID: 20927017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal PET imaging of tumor hypoxia during the course of radiotherapy.
    Stieb S; Eleftheriou A; Warnock G; Guckenberger M; Riesterer O
    Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2201-2217. PubMed ID: 30128659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging hypoxia in tumours with advanced MRI.
    Price JM; Robinson SP; Koh DM
    Q J Nucl Med Mol Imaging; 2013 Sep; 57(3):257-70. PubMed ID: 24045622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tracers in oncology - preclinical and clinical evaluation].
    Krause BJ; Schwarzenböck S; Schwaiger M
    Nuklearmedizin; 2010; 49 Suppl 1():S41-5. PubMed ID: 21152689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography for radiation treatment planning.
    Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
    Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
    Vallabhajosula S
    Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET and PET/CT studies of tumor tissue oxygenation.
    Krause BJ; Beck R; Souvatzoglou M; Piert M
    Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):28-43. PubMed ID: 16557202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential role of non-FDG-PET in the management of head and neck cancer.
    Heuveling DA; de Bree R; van Dongen GA
    Oral Oncol; 2011 Jan; 47(1):2-7. PubMed ID: 21109481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancements and future directions in positron emission tomography-guided radiotherapy: a narrative review.
    Mehta S; Yang C; Jadvar H; Colletti PM; Conti PS; Ma L; Chang EL; Ye JC
    Chin Clin Oncol; 2024 Apr; 13(2):24. PubMed ID: 38711177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A model to simulate tumour oxygenation and dynamic [18F]-Fmiso PET data.
    Kelly CJ; Brady M
    Phys Med Biol; 2006 Nov; 51(22):5859-73. PubMed ID: 17068369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Benefits of functional imaging in radiotherapy].
    Vera P; Thureau S
    Cancer Radiother; 2015 Oct; 19(6-7):538-42. PubMed ID: 26344445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.